Drw Securities, LLC Cti Biopharma Corp Transaction History

Drw Securities, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$1.72 - $5.24 $95,564 - $291,139	-55,561 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$3.81 - $5.26 $15,240 - $21,040	4,000 Added 7.76%	55,561 $277,000
Q4 2017 Feb 14, 2018	BUY	$2.47 - $3.34 $86,450 - $116,900	35,000 Added 211.34%	51,561 $138,000
Q3 2017 Nov 14, 2017	BUY	$3.12 - $3.65 $51,670 - $60,447	16,561	16,561 $53,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Drw Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Drw Securities, LLC with notifications on news.